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Abstract
 .  .The subcellular distributions of the enzymes which synthesise sphingomyelin SM and glucosylceramide GluCer from
ceramide have been assessed in BHK cells. On a sucrose density gradient GluCer synthase a marker of the cisrmedial
.Golgi apparatus and the trans-Golgi marker galactosyltransferase showed an similar monotonic distribution. In contrast,
SM synthase showed two peaks of activity, a minor one which migrated with the Golgi markers and a major one which had
a density close to that of plasma membrane markers sphingomyelin, cholesterol, PtdSer, ganglioside GM3 and alkaline
.phosphodiesterase . When cell homogenates were treated with digitonin, the sedimentation characteristics of the Golgi
markers was largely unaffected whereas the plasma membrane markers and the main peak of SM synthase activity were
 .shifted to higher density. In contrast, when cells were treated with brefeldin A BFA the Golgi markers were shifted to
higher density but not the plasma membrane markers or the main peak of SM synthase. These results suggest that the bulk
of SM synthase activity in BHK cells is not associated with the Golgi cisternae but with a cell compartment which is
 .relatively rich in cholesterol e.g., plasma membrane, endosomes or trans-Golgi network. Further experiments in which
cells were treated with sphingomyelinase provided evidence that SM synthase activity was in an internal compartment and
not at the plasma membrane. q 1997 Elsevier Science B.V.
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1. Introduction
The fact that cell plasma membranes are generally
enriched in sphingolipids, PtdSer and cholesterol has
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been thought to result from a gradual accumulation of
these lipids during the process of vesicular transport
through the Golgi apparatus so that their concentra-
tion increases in the cis “ trans direction from the
w xER to the plasma membrane 1,2 . However, despite
the notable advances which have been made in eluci-
dating the mechanisms by which proteins can be
selected and concentrated in the secretory pathway, it
is still difficult to understand how lipids like choles-
terol and SM can be similarly segregated for incorpo-
ration into the plasma membrane. Although it is now
generally believed that SM synthesis from ceramide
w xoccurs in the earlyrmid Golgi 2–4 and that this
lipid reaches the plasma membrane by vesicular
transport through the exocytic pathway, there is evi-
0167-4889r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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w xdence that although the movement of SM 5 and
w xcholesterol 6 to the cell surface involves vesicular
transport, this may not necessarily involve the Golgi
apparatus. Indeed, there is considerable evidence for
the presence of at least some SM synthase activity at
w xthe plasma membrane 3,7–11 and this could explain
why resynthesis of SM degraded at the cell surface
w xby sphingomyelinase occurs so rapidly 12,13 and is
unaffected by treatments which block vesicular trans-
w xport through the Golgi apparatus 14,15 . We have
proposed a scheme whereby plasma membrane SM is
made not in the Golgi but either directly in the
plasma membrane or at an endosomal site which is
wpart of the plasma membrane recycling pathway 16–
x18 . This model not only makes it easier to interpret
the effects of monensin and BFA on SM synthesis
and transport but also explains how the high choles-
terol and SM content of plasma membrane is main-
tained without the conceptual difficulty in under-
standing how segregation of lipids can occur between
successive cisternae in the Golgi. Clearly, a crucial
test of this model depends on a demonstration by
subcellular fractionation that SM synthesis can occur
at plasma membrane-related sites distinct from the
Golgi cisternae. That is what we have set out to do in
the present work.
2. Materials and methods
2.1. Materials
  6 N - 7 -n itro b en zo -2 -o x a -1 ,3 -d iazo l-4 -
. . yl amino hexanoyl-D-erythro-sphingosine NBD–
.ceramide and the glucosyl and phosphorylcholine
derivatives of NBD–ceramide NBD–glucosylcera-
.mide and NBD–sphingomyelin, respectively were
purchased from Molecular Probes, Eugene, OR, USA.
Standard lipids, digitonin, BFA, UDP–glucose and
 y1B. cereus sphingomyelinase 250 U ml in 50%
.glycerol were obtained from Sigma, Poole, Dorset,
UK and silica gel 60 tlc plates from Merck, Darm-
3  y1.stadt, Germany. Sodium H-acetate 56 mCi mmol
3  y1.and UDP– H-galactose 3–10 Ci mmol were ob-
tained from Amersham, Bucks, UK.
2.2. Cell culture, incubation and fractionation
BHK21 cells were cultured in Glasgow minimal
 .essential medium GMEM containing 5% foetal
 . w xbovine serum Gibco as described previously 12 .
Cells were generally grown to confluence over a
period of 48 h in 75 cm2 plastic flasks in the
presence of 1 mCi mly1 3H-acetate. They were
washed in serum-free GMEM and then incubated in
10 ml of the same medium at 378C for up to 1 h
either without further addition or in the presence of
 y1.B. cereus sphingomyelinase 0.1 U ml or brefeldin
 y1.A 5 mg ml .
Cells were washed four times at 08C with 50 ml of
a medium consisting of 137 mM NaCl, 5 mM KCl, 1
mM MgCl and 10 mM MOPS–NaOH buffer pH 7.02
 .Medium A . After draining, the cells were scraped
from the flasks into a final volume of 1 ml of the
Medium A and disrupted by 20 passages through a
25G needle attached to a 1 ml plastic syringe. In
some samples of cells, digitonin 100 mg in 0.1 ml
.Medium A was added to the homogenate at this
point. Nuclei and partly disrupted cells were sedi-
mented at 500 g for 3 min and the supernates ca. 1
.ml were applied to the top of linear sucrose density
gradients 10 ml volume, 15–50% wrv sucrose in
.Medium A and centrifuged at 35 000 rpm for 2 h at
48C in the 6=11 ml swingout rotor of a Kontron
Centrikon D-2190 ultracentrifuge. 0.5 ml fractions of
the gradient were taken from the top using an auto-
matic pipette. The gradient pellet was resuspended in
0.5 ml of Medium A. Sucrose concentrations and
hence the densities of fractions were measured using
a Bellingham Stanley refractometer.
Samples of each gradient fraction and of the ho-
mogenate, post-nuclear supernate, nuclear pellet re-
.supended in 1 ml of medium A and gradient pellet
w xwere assayed for protein 19 , SM synthase, GluCer
w xsynthase, alkaline phosphodiesterase 20 , b-
w x w xhexosaminidase 21 and galactosyltransferase 22 .
SM synthase and GluCer synthase were assayed si-
multaneously by incubating 0.3 ml samples of gradi-
ent fractions and 10–50 ml samples of the other
fractions in a total volume of 0.4 ml made up with
medium A with the addition of 10 mM NBD–cera-
mide, 1 mg mly1 bovine serum albumin, and 2.5 mM
 .UDP–glucose final concentrations . After incubation
at 378C for 1 h, the samples were quenched by the
addition of 1.9 ml 2:1 methanolrchloroform.
In some experiments, a time course of SM and
GluCer synthesis was determined as above but using
0.3 ml samples of pooled fractions from the Golgi
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Table 1
Distribution of protein, lipid and enzyme markers in BHK cell fractions
y3 y3Proteinrmg SMrcpm=10 PtdChorcpm=10 APDErnmolrh GTrnmolrh HEXrmmolrh SM synthrnmolrh GC synthrnmolrh
Control
Homogenate 1000 155 983 156 61 1.2 0.8 12.1
PN supernate 910 137 752 98 27 0.9 0.5 7.9
Nuclear pellet 110 21 220 45 19 0.4 0.3 2.9
Gradient pellet 100 23 179 35 2 0.1 0.1 0.8
Gradient fractions ND 76 259 58 14 0.3 0.3 3.3
Sphingomyelinase
Homogenate 1000 45 925 147 49 1.5 0.6 14.9
PN Supernate 790 37 629 110 24 1.1 0.3 9.1
Nuclear pellet 160 14 291 45 16 0.6 0.2 3.0
Gradient pellet 90 11 180 36 2 0.3 0.1 1.0
Gradient fractions ND 23 201 71 12 0.4 0.2 3.0
Digitonin
Homogenate 1000 126 938 157 56 1.4 0.8 13.4
PN supernate 780 91 647 136 24 1.0 0.5 8.7
Nuclear pellet 160 35 300 27 22 0.5 0.2 3.0
Gradient pellet 100 57 277 97 2 0.3 0.2 1.5
Gradient fractions ND 49 240 30 14 0.4 0.2 3.3
Brefeldin A
Homogenate 1000 149 946 164 57 1.3 1.3 15.5
PN supernate 710 106 622 129 24 1.1 0.8 11.5
Nuclear pellet 170 35 361 54 20 0.5 0.5 2.1
Gradient pellet 90 22 188 43 3 0.2 0.2 1.6
Gradient fractions ND 73 282 60 13 0.4 0.5 3.3
 .  .Samples of the homogenate, post-nuclear PN supernate and nuclear pellet were assayed for protein, SM and PtdCho radioactivity, alkaline phosphodiesterase APDE ,
 .  .  .galactosyltransferase GT , hexosaminidase HEX , SM synthase and GluCer GC synthase. Assays were carried out as described in Section 2. Treatment with
 y1.sphingomyelinase 0.1 U ml was for 10 min at 378C. Similar determinations were also carried out on the fractions from the sucrose density gradient including the
pellet. All values are normalised to 1 mg of protein in the homogenate which contained a total of about 4 mg protein and 800 nmol of phospholipid phosphorus or ca. 400
.nmol of PtdCho and are corrected to the original volume of the homogenate.
The data presented here refers to a single experiment which corresponds to the data of Fig. 1 and which was repeated on three further occasions with substantially the
same results.
NDsnot determined.
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 .region of the gradient fractions 4–8 and the plasma
 .membrane region fractions 10–14 .
2.3. Lipid analysis
A sample of mixed lipid equivalent to ca. 100
nmol of phosphorus obtained by extraction of bovine
brain was added as a carrier to all BHK cell lipid
extracts. Phase separation was carried out as de-
w x  .scribed previously 23 and the lower chloroform
phase was dried under vacuum. The dried lipid was
dissolved in 50 ml of chloroform and was chromato-
graphed on a tlc plate using a solvent consisting of
ch lo ro fo rm r m ethano lr ace tic ac id r w ater
 .70:30:0.2:6 to separate phospholipids and the fluo-
rescent lipids. In addition to the free NBD–ceramide
which ran close to the solvent front, two other fluo-
rescent lipid spots were identified by illumination
under a UV lamp, one migrating with an Rf of 0.7
and the other with Rf ca. 0.2. The faster component
was identified as NBD–glucosylceramide based on
comparison with an authentic standard and on its
disappearance when UDP–glucose was omitted from
the incubations. The slower component was NBD–
SM based on comparison with an authentic standard
and by its conversion to NBD–ceramide on treatment
with sphingomyelinase. The amount of NBD–SM
which was synthesised was not affected by omission
of UDP–glucose from the assay mixture. Spots con-
taining fluorescent lipids were excised from the plates
and extracted with 0.5 ml of 80% methanol overnight.
0.4 ml of this extract was placed in a multiwell plate
and analysed for total fluorescence using a Titertek
Fluoroskan II fluorimeter excitation 485 nm, emis-
.sion 538 nm . NBD–ceramide gave a fluorescence of
 .  .Fig. 1. Distribution of a PtdCho, PtdSer and cholesterol, b
 .SM, PtdIns and ganglioside GM3; c triacylglycerol and ce-
ramide from a BHK cell post-nuclear supernate fractionated on a
15–50% wrv sucrose density gradient. A post-nuclear supernate
from 3H-acetate-labelled cells was fractionated and lipids were
analysed as described in Section 2. Values represent dpm per
 .fraction. a Open circles: cholesterol; filled circles: PtdCho; open
 .squares: PtdSer. b Open triangles: PtdIns; closed triangles: SM;
 .filled squares: GM3. c Open squares: triacylglycerol; filled
circles: ceramide. Ceramide counts have been multiplied tenfold
in order to plot them on the same scale. This experiment was one
of four all showing similar results.
80 unit nmoly1 under these conditions and the same
value was assumed for NBD–glucosylceramide and
NBD–sphingomyelin. The fluorescence of blank
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samples eluted from tlc plates was about 0.1 unit.
Standards containing known amounts of NBD–lipids
were also chromatographed and eluted in the same
way; this procedure recovered close to 100% of the
fluorescent ceramide and GluCer but only about 75%
of the NBD–SM, for which an appropriate correction
was made.
After removal of the fluorescent spots, the plates
were stained with iodine vapour to reveal the areas
corresponding to phospholipids. These were excised,
eluted with 0.2 ml of methanolracetic acidrwater
 .5:2:3 and counted in 2 ml of Ultima Gold scintilla-
 .tion fluid Canberra Packard using a 2500TR Can-
berra Packard scintillation counter. In most experi-
ments, neutral lipids were also separated by tlc in a
solvent consisting of benzenerdiethyl etherrethanol
 .50:40:2 and similarly quantified by scintillation
counting. Standard phospholipids and neutral lipids
were run with all samples so that spots could be
identified after staining with iodine.
3. Results
w xAs noted previously 24 , cells grown for two days
with 3H-acetate showed a distribution of radioactivity
in their lipids which paralleled the relative masses of
the different lipid classes. In homogenates of un-
treated cells, approximately 70–80% of total lipid
radioactivity and about 80% of protein was found in
 .the post-nuclear supernate Table 1 . Somewhat
 .smaller proportions 60–70% of the total activity of
SM and GluCer synthases, galactosyltransferase, b-
hexosaminidase and alkaline phosphodiesterase were
 .also found in the postnuclear supernate Table 1 .
When this supernate was analysed on a linear 15–50%
w xwrv sucrose density gradient 25 , the peak of SM
radioactivity was at density 1.13 g mly1 and coin-
cided with the main peak of cholesterol, ganglioside
 .GM3 and PtdSer Fig. 1a–b , i.e., those lipids which
are characteristic of the plasma membrane in BHK
w xcells 24,26–29 . Ceramide, although only a very
small proportion of the total, also showed a peak in
this region but the main peak of triacylglycerol was
 .near the top of the gradient Fig. 1c , together with
w xthe bulk of the b-hexosaminidase activity 25 .
w xAs seen before 25 , an enzymic marker for plasma
 .membrane, alkaline phosphodiesterase Fig. 2a also
showed a peak which coincided with the lipid mark-
 .ers of plasma membrane, such as SM Fig. 2b . In
contrast, a marker of the trans-cisternae of the Golgi
Fig. 2. Effects of brefeldin A, digitonin and sphingomyelinase on
 .  .the distribution of a alkaline phosphodiesterase and b SM
radioactivity from a BHK cell post-nuclear supernate fractionated
on a 15–50% wrv sucrose density gradient. Post-nuclear super-
3 nates from H-acetate-labelled BHK cells either untreated open
.  .  .circles or treated with BFA triangles , digitonin squares or
 .  .sphingomyelinase 1 h treatment filled circles were fraction-
 .ated and assayed for alkaline phosphodiesterase a and SM
 .radioactivity b as described in Section 2. The experiment
illustrated is one of three carried out under the same conditions,
each giving similar results.
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apparatus, galactosyltransferase, had a distinctly dif-
ferent distribution, with a symmetrical peak centred
y1  .on fraction 7 at density 1.09 g ml Fig. 3a .
Glucosylceramide synthase also appeared to be largely
associated with the Golgi apparatus since its distribu-
tion on the density gradient closely resembled that of
 .galactosyltransferase Fig. 3a . However, although
there was significant SM synthase activity in the
Golgi region generally accounting for 20–25% of
.the total on the gradient , the main peak of activity
 .55–65% of the total sedimented close to that of the
 .plasma membrane markers Fig. 3a . The synthesis of
NBD–SM in the Golgi and plasma membrane re-
gions of the gradient was approximately linear over a
period of 30 min and increased up to 60 min Fig. 3a
.inset .
In attempts to further characterise the SM synthase
activity, cells were treated with BFA or sphin-
gomyelinase before homogenisation or with digitonin
after homogenisation. It was predicted that BFA
would affect the sedimentation characteristics of Golgi
markers because of its ability to fuse ER and Golgi
into a mixed vesicle population but that digitonin
would only affect the sedimentation characteristics of
membranes which contained cholesterol e.g., plasma
.membrane and endosomes while having little effect
w xon Golgi markers 30–35 .
As expected, BFA caused the dispersal of the
juxtanuclear organelle thought to correspond to the
Golgi apparatus into a multitude of small vesicles
surrounding the nucleus results of confocal mi-
.croscopy, not shown . Correspondingly, in the pres-
ence of BFA the normal sharp Golgi peak of galacto-
syltransferase was dispersed across the gradient into a
 .variety of higher and some lower density fractions
 .Fig. 3b . There was a similar effect on the distribu-
tion of glucosylceramide synthase although in both
cases, the total activity was not changed significantly.
In contrast, although the peak of SM synthase activity
in the Golgi region disappeared, the peak in the
plasma membrane region of the gradient remained
 .and was increased in size Fig. 3b . There was no
marked effect of BFA on the distribution of radioac-
 .tivity in SM Fig. 2b or on the distribution of
 .alkaline phosphodiesterase Fig. 2a .
In contrast to BFA, digitonin had no effect on the
distribution of galactosyltransferase, glucosylce-
ramide synthase or the minor peak of SM synthase
 .activity Fig. 3c but caused a marked shift of the
main peak of SM synthase activity to higher densities
 .including the gradient pellet Table 1 . Digitonin also
caused a movement of alkaline phosphodiesterase
activity and SM radioactivity to higher densities,
 .including the gradient pellet Fig. 2a–b; Table 1 .
Finally, treatment of cells with sphingomyelinase
for 10 or 60 min before fractionation caused the
expected large reduction in SM radioactivity, particu-
larly in the region of the gradient which was enriched
in plasma membrane but also in the lightest fraction
 .on the gradient Fig. 2b, Fig. 4a . Sphingomyelinase
degraded about 50% of total cellular SM after 10 min
and 70% after 1 h, but a region of the gradient
 .centred on fractions 16–17 density 1.15 showed
relatively less breakdown than other fractions Fig.
.2b, Fig. 4a . A resistant pool in this region of the
gradient was repeatedly observed in other similar
experiments. Sphingomyelinase treatment for 1 h but
.not for 10 min also caused a drop in synthesis of
NBD–SM in the plasma membrane region of the
 .gradient Fig. 4b whereas it had no effect on synthe-
 .sis of NBD–GluCer Fig. 4c and only a minor effect
 .on SM synthesis in the Golgi region Fig. 4b . Nei-
ther was there any significant effect of sphingomyeli-
nase treatment on the distribution of other lipids not
.  .shown , alkaline phosphodiesterase Fig. 2a , or
 .galactosyltransferase not shown .
Fig. 3. Effects of brefeldin A, digitonin and sphingomyelinase on the distribution of galactosyltransferase, glucosylceramide synthase, and
SM synthase from a BHK cell post-nuclear supernate fractionated on a 15–50% wrv sucrose density gradient. Post-nuclear supernates
3  .  .  .from H-acetate-labelled BHK cells either untreated a or treated with b BFA or c digitonin were fractionated and assayed as
 .  . described in Section 2. Measurements of galactosyltransferase filled circles GluCer synthase filled squares , and SM synthase open
.circles were carried out as described in Section 2. The values for SM synthase are multiplied by a factor of ten in order to plot them on
 .the same scale as the GluCer synthase. The experiment illustrated is one of three, each giving similar results. The inset to a shows the
 .  .time course of SM synthesis for pooled samples from the plasma membrane region filled circles and the Golgi region open circles of
the gradient, as detailed in Section 2.
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4. Discussion
4.1. Fractionation of radio-labelled BHK cells
BHK cells labelled to equilibrium with 3H-acetate
and fractionated on a sucrose density gradient gave
two main lipid peaks, the larger of which appeared to
correspond to plasma membrane in terms of density,
 . w xlipid composition and enzymic markers Fig. 1 25 .
The smaller lipid peak seen near the top of the
 .gradient fractions 2–3 coincided with the lysosomal
w xmarker b-hexosaminidase 25 and with arylsul-
 .phatase activity not shown and seems likely to
represent the so-called ‘floating lysosomes’ of BHK
cells described by Renkonen and his collaborators
w x28,36,37 . Such an interpretation is supported by the
observation that triacylglycerol levels were high in
 .this part of the gradient Fig. 1c since triacylglycerol
was a major component of the floating lysosomes
w x36,37 . However, this light fraction was depleted in
SM after sphingomyelinase treatment Fig. 2bFig.
.4a , so it seems likely also to contain some plasma
membrane-related components perhaps secondary
.endosomes . There was also an apparent peak of
alkaline phosphodiesterase activity in this region al-
though it is quite possible that this represents a
separate lysosomal activity, perhaps an acid phos-
phatase.
Although there was usually no clear lipid peak
near fraction 7, this region appeared to correspond to
the Golgi apparatus since galactosyltransferase, the
conventional marker enzyme for the trans-Golgi
showed a symmetrical peak in this part of the gradi-
 .ent Fig. 3a . This was confirmed by the presence of
 .GluCer synthase in the same region Fig. 3a, Fig. 4c ,
as this enzyme has previously been shown to be
w xassociated with the Golgi apparatus 38,39 . Indeed,
there is convincing evidence that it has a specific
 .Fig. 4. Effect of sphingomyelinase pretreatment of cells on a
 .  .SM radioactivity b SM synthase and c glucosylceramide
synthase activity in fractions of BHK cells separated on a 15–50%
wrv sucrose density gradient. Cells were incubated either alone
 . open circles or with 1 U of sphingomyelinase for 10 filled
.  .circles or 60 min squares before being washed and fractionated
 .  .and assayed for SM radioactivity a , SM synthase activity b
 .and glucosylceramide synthase activity c as described in Sec-
tion 2. The figure shown is representative of three experiments.
w xlocalisation in the early Golgi 11 but not with the
ERGIC fraction corresponding to the intermediate
w xcompartment between the ER and Golgi 40 . BHK
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cells treated with monensin, which blocks transport
w xbetween the medial- and trans-Golgi 41 show an
accumulation of GluCer and a drop in synthesis of
w xSM 14 , suggesting that synthesis of GluCer occurs
no later than the cis- or medial-Golgi. If this reason-
ing is correct, then the region around fraction 7 may
correspond to intact Golgi apparatus since it contains
 . both an early GluCer synthase and a late galacto-
.syltransferase Golgi marker. Alternatively, these en-
zyme markers could be in separate vesicular Golgi
subfractions which happen to have the same density,
although there is no reason to assume that the Golgi
cisternae all have the same density.
In all experiments, there was some SM synthase
activity in the Golgi region but there was always a
much more prominent peak of this activity at a
density close to that of the plasma membrane markers
 .Fig. 3a . This distribution of activity was observed at
 .shorter times of incubation Fig. 3a, inset and thus
did not appear to be an artefact due to differential
breakdown by endogenous sphingomyelinase or to
limitation of substrate, particularly the endogenous
PtdCho required for SM synthesis. The maximum
extent of synthesis of NBD–SM in these experiments
was about 50 pmol per fraction and the average
amount of PtdCho in each of the gradient fractions
was about 5 nmol so that only about 1% of the
PtdCho would have been consumed over the time
during which synthesis was measured. Thus, there is
no reason to think that substrate limitation would be a
problem or that addition of exogenous PtdCho would
have been beneficial.
Although the plasma membrane peak was poorly
w xseparated from smooth ER membranes 25 , no previ-
ous experimental evidence indicates that ER could be
a site of SM synthesis. SM synthase in rat liver has
previously been found mainly associated with the
earlyrmid Golgi region although some activity was
found in higher density fractions which may corre-
w xspond to the plasma membrane 3,4,11 . The reason
for this difference between liver and BHK cells is not
clear but it should be remembered that liver carries
out the synthesis and secretion of lipoproteins which
contain SM so that liver Golgi may require a SM
synthetic activity which is distinct from that involved
w xin plasma membrane biosynthesis 16,18 .
Alkaline phosphodiesterase distribution on the
density gradient coincided with the distribution of the
plasma membrane lipid markers but generally seemed
 .to show a sharper peak than SM Fig. 2 . This may
be because alkaline phosphodiesterase is present only
on exposed external faces of the plasma membrane
whereas the lipid markers would also label inside-out
plasma membrane fragments and endosomes which
are likely to appear polydisperse in terms of density
on a sucrose gradient.
4.2. Effects of brefeldin A
BFA treatment dispersed the Golgi-associated en-
 .zymes GluCer synthase and galactosyltransferase
from their normal gradient peak near fraction 7 Fig.
.  .3a into a variety of mainly higher density fractions
 .Fig. 3b , as expected if BFA causes vesiculation of
the Golgi and fusion of Golgi compartments with the
ER. The gradient distribution of these two enzymes
was not coincident after treatment with BFA but this
was not unexpected since GluCer synthase appears to
reside in earlier Golgi compartments whereas galac-
tosyltransferase is the classic late Golgi marker; there
is no reason to assume that the density of these
compartments is the same. There was little effect of
BFA on the distribution of plasma membrane mark-
ers alkaline phosphodiesterase and SM radioactivity,
.Fig. 2a–b and no pronounced change in the distribu-
tion of the main peak of SM synthase activity Fig.
.3b . A similar result has been obtained with HepG2
w xcells 42 . In contrast, it did appear that the Golgi-as-
sociated SM synthase activity was dispersed by BFA
and this may have contributed to the observed in-
crease in SM synthase activity in the middle of the
 .gradient Fig. 3b . However, it is difficult to explain
the almost two-fold increase in activity of SM syn-
thase activity in the gradient fractions of BFA-treated
cells. An increased SM synthesis in response to BFA
w xhas been reported previously in intact cells 15,43,44
but it is unclear why BFA should increase SM syn-
thase activity in cell fractions using NBD–ceramide
as substrate.
4.3. Effects of digitonin
A second important piece of evidence that the
main peak of SM synthase activity is not associated
with the Golgi apparatus is derived from experiments
with digitonin, which binds specifically to cholesterol
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and can consequently increase the density of plasma
membrane and related membranes without affecting
w xGolgi markers 30–35 . As expected, digitonin caused
a very marked shift in the peaks of alkaline phospho-
diesterase activity and SM radioactivity i.e., plasma
.  .membrane into higher density fractions Fig. 2a–b .
Crucially, it also caused a similar movement of the
main peak of SM synthase activity into higher den-
 .sity fractions Fig. 3c but in contrast, there was no
change in the activity or density of the GluCer syn-
thase or galactosyltransferase peaks. The implication
of this result is that the main fraction of SM synthase
activity is in a membrane which contains cholesterol,
SM and alkaline phosphodiesterase and is therefore
.probably plasma membrane-related whereas GluCer
synthase, galactosyltransferase and the minor fraction
of SM synthase are in membranes presumably the
.Golgi cisternae which contain very little cholesterol.
This conclusion supports our previous contention that
Golgi membranes even as far as the trans-cisternae
w xcontain little cholesterol 16,18 and conflicts with the
widely-held notion of a ‘cholesterol gradient’ through
w xthe Golgi cisternae 1 .
4.4. Effects of sphingomyelinase treatment
Treatment of cells with sphingomyelinase for 1 h
clearly caused the expected large drop in the amount
 .of SM in the cells Fig. 2b, Fig. 4a but without
 .having any noticeable effect on PtdCho not shown
or on the plasma membrane enzyme marker, alkaline
 .phosphodiesterase Fig. 2a . There was also a marked
decrease of NBD–SM synthesis in the plasma mem-
 .brane region of the gradient Fig. 4b but little effect
on the synthesis of NBD–GluCer or NBD–SM in the
 .Golgi region Fig. 4b–c . The most likely explanation
of a drop in synthesis of NBD–SM is that ceramide
produced originally at the cell surface as a result of
sphingomyelinase action is able to reach the site of
SM synthesis and to compete with NBD–ceramide
for conversion to SM. Since synthesis of GluCer and
SM synthase activity in the Golgi region were unaf-
fected by sphingomyelinase treatment of cells it seems
that ceramide from the cell surface cannot reach the
Golgi apparatus; this is consistent with previous evi-
w xdence that ceramide generated at the cell surface 17
w xor indeed, other plasma membrane components 45
cannot easily reach the Golgi cisternae. Thus, the
main localisation of SM synthase activity appears to
be either in the plasma membrane or in a compart-
ment which has some more direct vesicular com-
merce with the plasma membrane e.g., endosomes or
.TGN rather than in the Golgi cisternae. Interestingly,
the observation that a 10 min treatment of cells with
sphingomyelinase has no effect on synthesis of
 .NBD–SM Fig. 4b , despite causing 60–70% of
maximal SM breakdown, suggests that the plasma
membrane is not a major site of SM synthesis. This
short treatment would largely degrade the plasma
membrane pool of SM but not endosomal pools since
the time for endocytosis of half the plasma membrane
w xin BHK cells is about 40 min at 378C 46 so only
about 10% of the plasma membrane would be endo-
cytosed during a 10 min incubation. It is conceivable
that exogenous sphingomyelinase is endocytosed to a
significant extent during a 1 h incubation and that
this leads directly to a degradation of newly-synthe-
sised NBD–SM. Even if it did, this would also
support the evidence suggesting that SM synthase
activity is in an endosomal compartment rather than
the plasma membrane, as we have argued previously
w x17,18 .
A secondary point which emerges from the treat-
ment with sphingomyelinase is that the pool of SM in
BHK cells which is most resistant to the enzyme and
which presumably corresponds to the internal pool of
w xSM which we have described before 47 , appears to
be in a fraction of greater density than the plasma
 .membrane Fig. 2b, Fig. 4a and similar to that of an
w xER enzyme marker 25 . This would be consistent
with our original suggestion of a localisation of this
w xresistant pool in the ER 47 but would not exclude a
localisation in secondary endosomes.
4.5. Subcellular localisation of SM synthase acti˝ity
The above results strongly suggest that the bulk of
the SM synthase in BHK cells is not localised in the
Golgi apparatus but in a more distal compartment
which contains more cholesterol than the ER–Golgi
membranes, e.g., plasma membrane, endosomes or
possibly TGN. Such a localisation could explain why
BHK cells can readily resynthesise SM which has
been degraded to ceramide at the cell surface without
the ceramide needing to pass through the Golgi appa-
w xratus 17 . Likewise, it would explain why the density
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of the membranes bearing SM synthase activity is
unaffected by BFA which has dramatic effects on
.membranes bearing Golgi markers whereas the den-
sity of membranes containing SM synthase is in-
creased by digitonin which has no effect on the
equilibrium density of Golgi membranes. A separa-
tion of the site of SM synthesis from the Golgi
cisternae has also been observed in malaria parasites
w x48,49 and again in this case, BFA disassembles the
Golgi apparatus without affecting the localisation of
the SM synthase.
A further complication which could influence the
apparent relative activity of SM synthase in Golgi
and in the plasma membrane-related fraction from
BHK cells is variation in the amount and distribution
of ceramide after homogenisation of the cells. Since
there appears to be most endogenous ceramide in the
 .plasma membrane-associated fractions Fig. 1c which
would presumably compete with the added NBD–
ceramide used to assay SM synthase, this could lead
to an underestimate of activity in these fractions.
Thus, the relative activity in the plasma membrane
region could actually be higher than the measured
values.
Previous work does provide some evidence for
significant SM synthase activity in the plasma mem-
w x w xbrane of fibroblasts 50 , MDCK cells 9 and oligo-
w xdendrocytes 10 . However, the main peak of SM
synthase in BHK cells appeared to be generally of
somewhat wider density range than plasma mem-
brane as judged from the distribution of SM and
.alkaline phosphodiesterase and could include exo-
w xcytic 51 or endosomal elements related in composi-
tion to the plasma membrane. The presence of SM
 .synthase activity in endosomal or TGN fractions
rather than plasma membrane is indicated by the
inhibition of NBD–SM synthesis by a protracted
incubation with sphingomyelinase but not by a short
treatment which would only break down plasma
 .membrane SM see above and Fig. 4 . Thus these
results are consistent with our previous suggestion
that SM synthase activity is present in an endosomal
compartment where it plays a vital role in determin-
ing and maintaining plasma membrane lipid composi-
w xtion 17,18 .
However, recent work based on density shifts in-
duced by oxidation of diaminobenzidine by endocy-
tosed horseradish peroxidase has provided convincing
evidence against the idea that SM synthase is present
w xin an endosomal compartment 52 . This, together
with other reports based on the localization of fluo-
rescent ceramides and their corresponding sphin-
w xgomyelins in TGN 53–55 could represent support
for the alternative view that SM synthase is localised
in the TGN. If so, then our results suggest that the
TGN is not only rich in cholesterol but is accessible
to ceramide derived from the plasma membrane.
The status of the minor fraction of SM synthase
activity which migrates on the density gradient with
 .Golgi markers Fig. 2 is at present uncertain. It may
represent a distinct site of SM synthesis in the early
w xGolgi as suggested previously 3,4 and this would be
consistent with the observation that some SM synthe-
sis can still occur in cells where vesicular transport
w xthrough the Golgi is blocked by monensin 14 . It
could, as noted above, represent a separate enzyme
associated with the synthesis of lipoproteins, which
are relatively enriched in SM. Another possibility is
that the Golgi-associated SM synthase represents a
residual fragment of non-Golgi activity which re-
mains attached to the Golgi cisternae after homogeni-
sation. The structure of the Golgi complex in many
cells is intricate, with elements of endocytic compart-
w x w xments 56,57 including secondary endosomes 58
intercalated with the exocytic compartments and it is
possible that depending on the precise conditions of
homogenisation, more or less of these endocytic com-
partments remain attached to the Golgi cisternae.
Thus, it is conceivable that SM synthase activity
associated with Golgi markers actually represents
intercalated endosomal elements. Alternatively, in
view of the evidence mentioned above that SM syn-
w xthase is present in the TGN 53–55 the Golgi-associ-
ated activity could represent residual TGN still asso-
ciated with the Golgi cisternae.
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